|
211 |
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study Enthalten in BMC cancer Bd. 19, 21.6.2019, Nr. 1, date:12.2019: 1-9
|
|
|
212 |
Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial Enthalten in BMC cancer Bd. 13, 15.10.2013, Nr. 1, date:12.2013: 1-9
|
|
|
213 |
Klinische Endpunkte in Real-World-Register-Studien Enthalten in Der Onkologe Bd. 26, 28.4.2020, Nr. 6, date:6.2020: 530-541
|
|
|
214 |
Komplikationsmanagement in der Brustchirurgie Enthalten in Der Gynäkologe Bd. 49, 18.12.2015, Nr. 3, date:3.2016: 180-184
|
|
|
215 |
LEFTY2 inhibits endometrial receptivity by downregulating Orai1 expression and store-operated Ca2+ entry Enthalten in Journal of molecular medicine Bd. 96, 11.12.2017, Nr. 2, date:2.2018: 173-182
|
|
|
216 |
Mammotome® versus ATEC®: a comparison of two breast vacuum biopsy techniques under sonographic guidance Enthalten in Archives of gynecology and obstetrics Bd. 281, 30.4.2009, Nr. 2, date:2.2010: 287-292
|
|
|
217 |
Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer Enthalten in BMC cancer Bd. 13, 5.7.2013, Nr. 1, date:12.2013: 1-8
|
|
|
218 |
Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy Enthalten in BMC cancer Bd. 8, 26.2.2008, Nr. 1, date:12.2008: 1-10
|
|
|
219 |
Perioperative adverse events associated with pelvic organ prolapse repair by nerve-preserving sacropexy: an analysis of 768 cases over a 10-year period Enthalten in Archives of gynecology and obstetrics Bd. 298, 21.6.2018, Nr. 2, date:8.2018: 353-361
|
|
|
220 |
Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers Enthalten in Journal of cancer research and clinical oncology Bd. 132, 22.12.2005, Nr. 4, date:4.2006: 265-274
|
|